English | Español
Robert Hadley | Jul 7, 2017

Testing underway for CytomX’s immunotherapy drug for cancer patients

Robert Hadley | Jul 7, 2017

$3.3 million in funding to aid research on inherited heart-valve defect
Robert Hadley | Jul 7, 2017

Protein loss after heart surgery linked to lymph system

LocalLabs News Service | Jul 7, 2017

AbbVie’s hepatitis C drug pending approval in Europe 
Robert Hadley | Jul 7, 2017

Astellas says gilteritinib may be long-sought treatment in certain acute myeloid leukemia cases
Robert Hadley | Jul 5, 2017

AbbVie shares findings of leukemia drug study at Madrid conference

Robert Hadley | Jul 5, 2017

AstraZeneca’s Faslodex to treat breast cancer a step closer to approval in Europe
Robert Hadley | Jul 5, 2017

European regulators consider expanding use of Amgen parathyroid drug to young patients

Trending
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
+ Pharmaceuticals
Patient Daily | Nov 10, 2025

Political commentator on 340B abuse: 'They're lining pockets, not helping patients'
+ Pharmaceuticals
Patient Daily | Nov 7, 2025

Bliksem Health founder on 340B reform: 'Health systems buy drugs at steep discounts and pocket the spread'
+ Pharmaceuticals
Patient Daily | Nov 10, 2025

Rep. DeGraaf on 340B program: ‘340B providers statistically provide less unreimbursed care’